DANHSON is a pharmaceutically-oriented holding company, established in Bulgaria in 2015, by professionals with long experience in the field. The core business is development, production and marketing of pharmaceutical products (RX and OTC), food supplements and cosmetics.
Main markets are Russian Federation, CIS, and the Balkans. Continues investment in production capacities either through acquisition of well-respected and established companies, or through investment from green field, in combination with analytical and technological know-how, guarantees high-quality service to our clients.
DANHSON is seeking to enlarge its presence worldwide and attract partners for its main activities.
Pharmaceutical Plants Milve Ltd
The company provides quality pharmaceutical production, meeting the GMP standards and high expectations of consumers. The company produces a wide range of medicinal products with different therapeutic uses.
one of the largest manufacturers of pharmaceutical products and food supplements in Vietnam, est. 1965
Dominanta – Servis
a rapidly developing modern pharmaceutical company based near Moscow, and a leading distributor on the Russian market, est.1996
Dominanta – Pharmaceutical Logopark
a modern pharmaceutical logistics centre covering an area of 60 acres
The major markets where DANHSON has successful presence with its products, are as follows:
- Central Asian countries: Kazakhstan, Kyrgyzstan, Uzbekistan, Tajikistan
- Caucasus region countries: Georgia, Armenia, Azerbaijan
- Baltic region countries, etc.
DANHSON has a representative offices in Kazakhstan and in Belarus
Over the past three years the company invested BGN 50 million in the construction of:
New production site with separate workshops for manufacturing of ampoule forms, liquid forms in vials, semisolid and biological products.
Warehouse complex with modern cutting-edge equipment.
R&D laboratories for development of new products and formulas, equipped with the latest technology.
DANHSON keeps enriching its portfolio of medicinal products, dietary supplements and medical devices.
Submitted for approval by BDA: more than 15 new products.
In the process of development in 2019 : more than 20 products.
Our main mission is to actively develop the production of innovative and highly effective medicines and food supplements.
Being a socially responsible company, DANHSON keeps investing in the creation and expanding of its team.
Leading specialists work at DANHSON in the pharmaceutical sphere, taking care to constantly renew and expand the product portfolio in compliance with market requirements.
DANHSON employees are a team of people sharing the same view, i.e. to develop products helping people to enjoy excellent health, self confidence and quality of life.